PROS1 and COVID-19: The outcomes of biochemical and biophysical experiments, presented in this study, provide novel knowledge on molecular determinants of the complex between LF and the S-protein of SARS-CoV-2, which may be instrumental to produce novel supplemental tools of higher effectivity for the treatment of COVID-19.